Annual report [Section 13 and 15(d), not S-K Item 405]

Note 18 - Subsequent Events

v3.26.1
Note 18 - Subsequent Events
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Subsequent Events [Text Block]

18. Subsequent Events

 

The Company has evaluated subsequent events through the filing of this Form 10-K, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements.

 

On January 2, 2026, the Company issued 1,358,000 shares of its Common Stock, subject to the limitations of Listing Rule 5635 of The Nasdaq Stock Market LLC, to DeeptradeX.ai, an Australian-based digital asset trading platform. The issuance was made pursuant to a purchase agreement entered into in December 2025, under which the Company agreed to acquire an aggregate of 25,937,800 native utility digital tokens issued by the seller (the “DTT Tokens”). The DTT Tokens are intended to function as a medium of exchange for services on the seller’s Web3.0 digital asset platform and do not represent equity, debt, dividends, governance rights, or profit-sharing interests. The total consideration for the DTT Tokens is $2,593,780, payable, at the Company’s election, in cash, shares of Common Stock, or a combination thereof. The Board of Directors of the Company approved payment of the consideration through the issuance of the 1,358,000 shares of Common Stock. The Consideration Shares were issued in reliance on the exemptions from registration provided by Section 4(a)(2) of the Securities Act, and/or Regulation D promulgated thereunder. The DTT Tokens will be delivered to a wallet address designated by the Company and will be subject to a 12-month lock-up period followed by a 24-month linear vesting period, with releases occurring automatically pursuant to an immutable smart contract. The purchase agreement contains customary representations, warranties, and covenants, including representations regarding regulatory compliance, token functionality, and indemnification for certain regulatory matters.